Related Experiment Video
Updated: May 2, 2026

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis
Published on: December 8, 2023
Cord blood banking and transplantation: advances and controversies
1Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Insights
Cord blood banking and stem cell transplantation have advanced significantly, benefiting over 30,000 patients. Future research into expanding cord blood stem cells may increase demand for this vital therapy.
Area of Science:
- Hematology
- Regenerative Medicine
- Transplant Immunology
Background:
- Umbilical cord blood (UCB) stem cell transplantation is a recognized alternative for hematopoietic stem cell transplants.
- UCB is particularly valuable for patients from racial and ethnic minority groups.
- The first human cord blood transplant occurred 25 years ago, marking a significant milestone.
Purpose of the Study:
- To review advancements in cord blood banking and stem cell transplantation since January 2012.
- To assess the current state and future potential of UCB therapies.
Main Methods:
- Systematic review of articles published since January 2012.
- Analysis of trends in cord blood banking and transplantation practices worldwide.
Main Results:
- Cord blood banking is globally established.
- UCB transplantation is a viable option for pediatric and adult patients.
- Enhancement methods for UCB stem cell expansion, engraftment, and maintenance are needed.
- Debate continues regarding optimal and sustainable cord blood banking models.
Conclusions:
- Cord blood banking and transplantation have seen rapid progress in 25 years, with over 30,000 patients treated.
- Emerging techniques for expanding UCB stem cells for transplantation and non-hematopoietic uses are expected to drive future demand.
Purpose Of Review:
A review of articles published since January 2012 on the topic of cord blood banking and cord blood stem cell transplantation was conducted for this the 25th anniversary year of the first cord blood transplant performed in a human.
Recent Findings:
Cord blood banking is performed throughout the world. Umbilical cord blood (UCB) transplantation is recognized as an acceptable alternative stem cell source for paediatric and adults requiring a haematopoietic transplant, particularly for patients of racial and ethnic minorities. To further advance the use of UCB, methods to enhance UCB stem cell expansion, engraftment and maintenance may be required. Controversy on the most effective and economically sustainable model for banking and storing an optimal UCB product continues to persist.
Summary:
Cord blood banking and transplantation of cord blood stem cells has advanced rapidly over the initial 25 years, as more than 30 ,000 patients have benefited from the therapy. New concepts on the use of methods to expand UCB stem cells for transplantation and use for nonhaematopoietic indications may increase demand for UCB over the next few decades.
More Related Videos
05:32In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells
Published on: February 16, 2024
11:59Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Kidney Transplant I: Introduction
Regulation of Hematopoietic Stem Cells